Interestingly, hemodialysis patients on short-term EPO treatment showed improved glucose metabolism indicated by a reduction in insulin resistance and decreased glycated hemoglobin and hyperleptinemia (Osman et al., 2017). This evidence concerns the gene EPO and Insulin resistance.